Literature DB >> 222713

Myoclonic encephalopathy of infants or "dancing eyes syndrome". Report of 7 cases with long-term follow-up and review of the literature (cases with and without neuroblastoma).

E Boltshauser, T Deonna, H R Hirt.   

Abstract

We describe 7 children with myoclonic encephalopathy of infants (MEI). MEI is a clinical entity characterized by an acute or subacute onset of polymyoclonia, cerebellar ataxia and opsoclonus ("dancing eyes"). It occurs either spontaneously, following an infectiuos illness or in association with an occult neuroblastoma. It is likely that immunological factors play a role in the pathogenesis. Steroid therapy resulted in rapid dramatic improvement of the neurological symptoms in 4 cases. However, this initial response did not correlate with the eventual outcome. We reviewed the literature to compare 45 reported cases of MEI associated with a neuroblastoma with 48 children without such a tumor to identify possible differences in clinical presentation, response to steroid medication and long-term prognosis of the neurological syndrome. In this respect we found no differences. Impairment of motor, verbal or intellectual performance were reported in at least half the cases. Although an immediate and marked response to steroids occurs in many cases of both groups, it remains unclear whether the long-term outcome is favourably influenced by this medication. The two-year-survival rate (90%) in the neuroblastoma group and the percentage of mediastinal localisation of the tumor (49%) are much higher compared with neuroblastomas without MEI. The reasons for these remarkable differences are not known. Diagnostic, therapeutic and prognostic implications justify the separation of MEI from the more common and benign syndrome known as acute cerebellar ataxia of childhood.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222713

Source DB:  PubMed          Journal:  Helv Paediatr Acta        ISSN: 0018-022X


  13 in total

Review 1.  Neuroblastoma as a neurobiological disease.

Authors:  N F Schor
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Opsoclonus as a presenting symptom in thymic carcinoma.

Authors:  M Schwartz; B Sharf; J Zidan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-06       Impact factor: 10.154

3.  Neurological sequelae of the dancing eye syndrome.

Authors:  K R Pohl; J Pritchard; J Wilson
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

4.  Paraneoplastic opsoclonus-myoclonus in Hodgkin's disease.

Authors:  C L Kay; G A Davies-Jones; R Singal; D A Winfield
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-07       Impact factor: 10.154

5.  Opsoclonus and polymyoclonia complicating oat-cell carcinoma of the bronchus.

Authors:  B D Sheinman; J Gawler
Journal:  Postgrad Med J       Date:  1982-11       Impact factor: 2.401

6.  Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases.

Authors:  Claudio Gambini; Massimo Conte; Gabriella Bernini; Paola Angelini; Andrea Pession; Paolo Paolucci; Alberto Donfrancesco; Edvige Veneselli; Katia Mazzocco; Gian Paolo Tonini; Lizzia Raffaghello; Carlo Dominici; Adriana Morando; Francesca Negri; Anna Favre; Bruno De Bernardi; Vito Pistoia
Journal:  Virchows Arch       Date:  2003-04-23       Impact factor: 4.064

7.  Paraneoplastic papilloedema in neuroblastoma.

Authors:  M J Kennedy; P Eustace; D S O'Briain; P A Daly
Journal:  Postgrad Med J       Date:  1987-10       Impact factor: 2.401

8.  Opsoclonus-myoclonus syndrome: correlation of radiographic and pathological observations.

Authors:  R F Tuchman; L A Alvarez; A B Kantrowitz; F G Moser; J Llena; S L Moshé
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

9.  Steroid-dependent form of Kinsbourne syndrome: successful treatment with trazodone.

Authors:  M Papini; A Pasquinelli; A Filippini
Journal:  Ital J Neurol Sci       Date:  1992-05

10.  Cerebellar ataxia and opsoclonus as the initial manifestations of myoclonic encephalopathy associated with neuroblastoma.

Authors:  S Harel; U Yurgenson; G Rechavi; Y Burstein; Z Spirer
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.